{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:36:20Z","timestamp":1769945780347,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Medical Research Council and National Research Foundation of South Africa","award":["85642"],"award-info":[{"award-number":["85642"]}]},{"name":"Medical Research Council and National Research Foundation of South Africa","award":["80647"],"award-info":[{"award-number":["80647"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.lfs.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T18:50:11Z","timestamp":1413312611000},"page":"56-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties"],"prefix":"10.1016","volume":"117","author":[{"given":"Anzelle","family":"Delport","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian H.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u00e9l","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus P.","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2014.10.005_bb0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0090-9556(25)08471-5","article-title":"Inhibition of monoamine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue","volume":"24","author":"Aeschlimann","year":"1996","journal-title":"Drug Metab Dispos"},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2014.10.005_bb0010","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1016\/S0924-977X(11)70674-5","article-title":"P.2.e.001. Methylene blue for residual symptoms and for cognitive dysfunction in bipolar disorder: results of a double-blind trial","volume":"21","author":"Alda","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2014.10.005_bb0015","series-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2014.10.005_bb0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2010-100414","article-title":"Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase","volume":"20","author":"Atamna","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.lfs.2014.10.005_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1527-3458.2003.tb00245.x","article-title":"Moclobemide: therapeutic use and clinical studies","volume":"9","author":"Bonnet","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.lfs.2014.10.005_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00702-007-0806-5","article-title":"Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies","volume":"115","author":"Brink","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.lfs.2014.10.005_bb0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/j.1552-4604.1989.tb03376.x","article-title":"The monoamine oxidase inhibitor\u2013tyramine interaction","volume":"29","author":"Brown","year":"1989","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.lfs.2014.10.005_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1399-5618.2002.01203.x","article-title":"Antidepressants and neuroplasticity","volume":"4","author":"D'Sa","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.lfs.2014.10.005_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.niox.2011.02.002","article-title":"Nitric oxide and major depression","volume":"24","author":"Dhir","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.lfs.2014.10.005_bb0055","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/phrs.1997.0245","article-title":"Anxiolytic and antidepressant properties of methylene blue in animal models","volume":"36","author":"Ero\u011flu","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.lfs.2014.10.005_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.psy.47.1.1","article-title":"Review of the literature on major mental disorders in adult patients with mitochondrial diseases","volume":"47","author":"Fattal","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1016\/j.lfs.2014.10.005_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.dyepig.2005.06.011","article-title":"The synthesis and properties of unsymmetrical 3,7-diaminophenothiazin-5-ium iodide salts: potential photosensitisers for photodynamic therapy","volume":"71","author":"Gorman","year":"2006","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.lfs.2014.10.005_bb0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pneurobio.2005.06.001","article-title":"The physiology and pathophysiology of nitric oxide in the brain","volume":"76","author":"Guix","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0085","first-page":"113","article-title":"Experiments on vital staining with methylene blue","volume":"94","author":"Harris","year":"1953","journal-title":"Q J Microsc Sci"},{"key":"10.1016\/j.lfs.2014.10.005_bb0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1099-1077(199607)11:4<309::AID-HUP775>3.0.CO;2-B","article-title":"Affective disorders and nitric oxide: a role in pathways to relapse refractoriness?","volume":"11","author":"Harvey","year":"1996","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/hup.946","article-title":"Is major depressive disorder a metabolic encephalopathy?","volume":"23","author":"Harvey","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.bcp.2010.07.037","article-title":"Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues","volume":"80","author":"Harvey","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0105","doi-asserted-by":"crossref","first-page":"15761","DOI":"10.1074\/jbc.M500949200","article-title":"Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors","volume":"280","author":"Hub\u00e1lek","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2014.10.005_bb0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0003-9861(88)90393-1","article-title":"Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins","volume":"262","author":"Kelner","year":"1988","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.lfs.2014.10.005_bb0115","series-title":"Drug-like properties: concepts, structure design, and methods: from ADME to toxicity optimization","author":"Kerns","year":"2008"},{"key":"10.1016\/j.lfs.2014.10.005_bb0120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pnpbp.2007.08.032","article-title":"Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder","volume":"32","author":"Korff","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0135","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2014.10.005_bb0140","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.pnpbp.2007.05.002","article-title":"Effects of various classes of antidepressants in behavioral paradigms of despair","volume":"31","author":"Kulkarni","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0145","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(94)91839-2","article-title":"Prophylaxis and reversal of ifosfamide encephalopathy with methylene blue","volume":"343","author":"K\u00fcpfer","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2014.10.005_bb0150","doi-asserted-by":"crossref","first-page":"e46585","DOI":"10.1371\/journal.pone.0046585","article-title":"Methylene blue as a cerebral metabolic and hemodynamic enhancer","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2014.10.005_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.dyepig.2010.09.001","article-title":"Synthesis and in vitro antiprotozoal activities of water-soluble, inexpensive phenothiazinium chlorides","volume":"89","author":"Lu","year":"2011","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.lfs.2014.10.005_bb0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S1092852912000594","article-title":"Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression","volume":"17","author":"Lum","year":"2012","journal-title":"CNS Spectr"},{"key":"10.1016\/j.lfs.2014.10.005_bb0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0922-4106(95)00084-4","article-title":"Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase","volume":"290","author":"Luo","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0170","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0006-3223(03)00117-3","article-title":"Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression","volume":"53","author":"Manji","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0175","first-page":"204","article-title":"Selective inhibitors of neuronal nitric oxide synthase-is no NOS really good NOS for the nervous system?","volume":"18","author":"Moore","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.lfs.2014.10.005_bb0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.lfs.2014.10.005_bb0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","article-title":"The role of nitric oxide in cardiovascular diseases","volume":"26","author":"Naseem","year":"2005","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.lfs.2014.10.005_bb0190","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0006-3223(86)90265-9","article-title":"A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis","volume":"21","author":"Naylor","year":"1986","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0006-3223(87)90194-6","article-title":"A controlled trial of methylene blue in severe depressive illness","volume":"22","author":"Naylor","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2014.10.005_bb0210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bcp.2009.04.034","article-title":"Methylene blue and Alzheimer's disease","volume":"78","author":"Oz","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1476-5381.2011.01462.x","article-title":"Methylene blue inhibits function of the 5-HT transporter","volume":"166","author":"Oz","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0215","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4088\/JCP.12m07648","article-title":"Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures","volume":"73","author":"Pae","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.lfs.2014.10.005_bb0220","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.taap.2011.12.005","article-title":"Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase","volume":"258","author":"Petzer","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0225","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1055\/s-0033-1345163","article-title":"The inhibition of monoamine oxidase by esomeprazole","volume":"63","author":"Petzer","year":"2013","journal-title":"Drug Res (Stuttg)"},{"key":"10.1016\/j.lfs.2014.10.005_bb0230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0235","series-title":"Current protocols in pharmacology","first-page":"581","article-title":"Models of affective illness: forced swimming and tail suspension tests in rodents","author":"Porsolt","year":"2000"},{"key":"10.1016\/j.lfs.2014.10.005_bb0240","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/clpt.1992.159","article-title":"Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects","volume":"52","author":"Provost","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lfs.2014.10.005_bb0245","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.bjp.0707430","article-title":"Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction","volume":"152","author":"Ramsay","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0250","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2005.02.001","article-title":"Memory facilitation by methylene blue: dose-dependent effect on behaviour and brain oxygen consumption","volume":"511","author":"Riha","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1749-6632.2001.tb05829.x","article-title":"Role of gaseous neurotransmitters in the hypothalamic-pituitary-adrenal axis","volume":"933","author":"Rivier","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lfs.2014.10.005_bb0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0006-2952(91)90311-R","article-title":"Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia\/reperfusion injury","volume":"42","author":"Salaris","year":"1991","journal-title":"Biochem Pharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2014.10.005_bb0265","first-page":"1","article-title":"Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence","volume":"10","author":"Sartorius","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2014.10.005_bb0270","first-page":"25","article-title":"A neuroscientific update on monoamine oxidase and its inhibitors","volume":"18","author":"Schwartz","year":"2013","journal-title":"CNS Spectr"},{"key":"10.1016\/j.lfs.2014.10.005_bb0275","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","article-title":"Structure of human monoamine oxidase A at 2.2-\u00c5 resolution: the control of opening the entry for substrates\/inhibitors","volume":"105","author":"Son","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lfs.2014.10.005_bb0280","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1177\/0269881109105450","article-title":"Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium","volume":"24","author":"Stanford","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0327(00)00164-6","article-title":"Elevated plasma nitrate levels in depressive states","volume":"63","author":"Suzuki","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.lfs.2014.10.005_bb0290","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-5793(97)00767-9","article-title":"Stimulation of respiration by methylene blue in rat liver mitochondria","volume":"412","author":"Visarius","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.lfs.2014.10.005_bb0295","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-8993(99)01253-6","article-title":"Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo","volume":"826","author":"Volke","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2014.10.005_bb0300","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0143-7208(03)00021-4","article-title":"Phenothiazinium photosensitisers: choices in synthesis and application","volume":"57","author":"Wainwright","year":"2003","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.lfs.2014.10.005_bb0305","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00428-009-0734-x","article-title":"Turquoise to dark green organs at autopsy","volume":"454","author":"Warth","year":"2009","journal-title":"Virchows Arch"},{"key":"10.1016\/j.lfs.2014.10.005_bb0310","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(02)03738-1","article-title":"Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity","volume":"959","author":"Wegener","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2014.10.005_bb0315","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1461145709990241","article-title":"Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression","volume":"13","author":"Wegener","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.lfs.2014.10.005_bb0320","unstructured":"Wischik, C.M., Rickard, J.E., Harrington, C.R., Horsley, D., Storey, J.M.D., Marshall, C., Sinclair, J.P., Wan Tan, H., 2006. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride. Patent: US 2006\/0287523 A1."},{"key":"10.1016\/j.lfs.2014.10.005_bb0325","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0161-813X(03)00103-7","article-title":"Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation","volume":"25","author":"Youdim","year":"2004","journal-title":"Neurotoxicology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514008200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514008200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:17:04Z","timestamp":1746418624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320514008200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0024320514008200"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2014.10.005","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}